Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Drreddys Laboratories

Drreddys Laboratories reported INR321.85B in Assets for its fiscal quarter ending in March of 2023.

Assets Change
ANI Pharmaceuticals ANIP:US USD 765.22M 5.14M
Bayer BAYN:GR EUR 125.05B 175M
Catalent CTLT:US USD 11.15B 942M
Corcept Therapeutics CORT:US USD 617.85M 34.42M
Drreddys Laboratories RDY:US INR 321.85B 12.55B
Endo International ENDP:US USD 5.57B 191.83M
GlaxoSmithKline GSK:LN GBP 58.6B 1.55B
Hikma Pharmaceutical HIK:LN USD 4.47B 276M
Horizon Pharma HZNP:US USD 8.99B 121.17M
Lonza Group LONN:SW CHF 17.36B 613M
Novartis NOVN:VX USD 112.24B 5.21B
Pacira PCRX:US USD 1.52B 157.78M
Phibro Animal Health PAHC:US USD 965.43M 3.6M
Prestige Brands PBH:US USD 3.35B 396.04M
Richter Gedeon RICHT:HB HUF 1.37T 29.14B
Supernus Pharmaceuticals SUPN:US USD 1.79B 89.3M
Teva Pharmaceutical Industries Ltd TEVA:IT USD 43.46B 550M